Safety and Efficacy of Nonanesthesiologist-Administrated Propofol during Endoscopic Submucosal Dissection of Gastric Epithelial Tumors

Table 1

Baseline characteristics.

	ASA 1	ASA 2	ASA 3	value
Patients ()	182	273	67
Median age (years (range))	63.5 (34.0-89.0)	72.0 (51.0-93.0)	72.0 (49.0-95.0)	<0.001
Sex
Male/female	127/55	194/79	55/12	0.139
BMI				<0.001
Comorbidity
Hypertension	0	207	57
Diabetes mellitus	0	70	23
Heart disease	0	52	46
Respiratory dysfunction	0	23	17
Renal dysfunction	0	20	16
Cerebral dysfunction	0	39	15
Anticoagulant/antiplatelet agents (n (%))	9 (4.94)	75 (27.4)	39 (58.2)	<0.001
Warfarin	0	10	13
Aspirin	3	19	17
Clopidogrel	0	11	9
Ethyl icosapentate	2	4	1
Cilostazol	0	3	1
Limaprost alfadex	3	6	0
Heparin bridge (n (%))	0 (0)	21 (7.69)	16 (23.8)	<0.001
Location				0.141
Upper	44	75	23
Middle	72	98	36
Lower	77	125	14
Macroscopic type
0-I	7	7	4
0-IIa	87	124	24
0-IIb	14	23	2
0-IIc	80	132	38
0-	5	11	1
0-	0	1	4